Cell non-autonomous functions of homeoproteins in neuroprotection in the brain

FEBS Letters

Volumn 585, Issue 11, 2011, Pages 1573-1578

  Joshi, Rajiv L ^a,b   Ibad, Raoul Torero ^a,b   Rheey, Jinguen ^a,b   Castagner, Franois ^a,b   Prochiantz, Alain ^a,b   Moya, Kenneth L ^a,b  

^a PSL RESEARCH UNIVERSITY   (France)

^b PSL RESEARCH UNIVERSITY   (France)

Author keywords

Dopaminergic; Glaucoma; Homeoprotein; Neurodegeneration; Neuron survival; Parkinson's disease; Protein transduction

Indexed keywords

ALPHA SYNUCLEIN; DOPAMINE; ENGRAILED 1 HOMEOPROTEIN; HOMEODOMAIN PROTEIN; TRANSCRIPTION FACTOR OTX2; UNCLASSIFIED DRUG;

CELL DEATH; CELL FUNCTION; CELL LOSS; CELL SURVIVAL; DEGENERATIVE DISEASE; DOPAMINERGIC NERVE CELL; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MECHANISM; GLAUCOMA; HUMAN; LOSS OF FUNCTION MUTATION; LOW DRUG DOSE; MESENCEPHALON; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; OPTIC NERVE DISEASE; PARKINSON DISEASE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; RETINA GANGLION CELL; REVIEW; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; THALAMUS VENTRAL NUCLEUS; VISION;

MUS;

EID: 79957558888     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2011.05.006     Document Type: Review

References (52)

1. W.J. Gehring Homeo boxes in the study of development Science 236 1987 1245 1252 (Pubitemid 17087888)
2. D. Duboule, and G. Morata Colinearity and functional hierarchy among genes of the homeotic complexes Trends Genet. 10 1994 358 364 (Pubitemid 24305375)
3. E. Boncinelli Homeobox genes and disease Curr. Opin. Genet. Dev. 7 1997 331 337 (Pubitemid 27292284)
4. D.D. O'Leary, S.J. Chou, and S. Sahara Area patterning of the mammalian cortex Neuron 56 2007 252 269
5. I. Brunet, A.A. Di Nardo, L. Sonnier, M. Beurdeley, and A. Prochiantz The topological role of homeoproteins in the developing central nervous system Trends Neurosci. 30 2007 260 267 (Pubitemid 46802831)
6. A. Prochiantz Messenger proteins: homeoproteins, TAT and others Curr. Opin. Cell Biol. 12 2000 400 406 (Pubitemid 30453588)
7. A. Prochiantz, and A. Joliot Can transcription factors function as cell-cell signalling molecules? Nat. Rev. Mol. Cell Biol. 4 2003 814 819 (Pubitemid 37229378)
8. B. Lesaffre, A. Joliot, A. Prochiantz, and M. Volovitch Direct non-cell autonomous Pax6 activity regulates eye development in the zebrafish Neural Dev. 2 2007 2
9. I. Brunet, C. Weinl, M. Piper, A. Trembleau, M. Volovitch, W. Harris, A. Prochiantz, and C. Holt The transcription factor Engrailed-2 guides retinal axons Nature 438 2005 94 98 (Pubitemid 41599826)
10. A. Wizenmann Extracellular Engrailed participates in the topographic guidance of retinal axons in vivo Neuron 64 2009 355 366
11. S. Sugiyama, A.A. Di Nardo, S. Aizawa, I. Matsuo, M. Volovitch, A. Prochiantz, and T.K. Hensch Experience-dependent transfer of Otx2 homeoprotein into the visual cortex activates postnatal plasticity Cell 134 2008 508 520
12. I. Topisirovic, and K.L. Borden Homeodomain proteins and eukaryotic translation initiation factor 4E (eIF4E): an unexpected relationship Histol. Histopathol. 20 2005 1275 1284 (Pubitemid 41489170)
13. A.A. Di Nardo, S. Nedelec, A. Trembleau, M. Volovitch, A. Prochiantz, and M.L. Montesinos Dendritic localization and activity-dependent translation of Engrailed1 transcription factor Mol. Cell. Neurosci. 35 2007 230 236 (Pubitemid 46843560)
14. W. Dauer, and S. Przedborski Parkinson's disease: mechanisms and models Neuron 39 2003 889 909 (Pubitemid 37130207)
15. T.M. Dawson, and V.L. Dawson Molecular pathways of neurodegeneration in Parkinson's disease Science 302 2003 819 822 (Pubitemid 37339614)
16. A.J. Lees, J. Hardy, and T. Revesz Parkinson's disease Lancet 373 2009 2055 2066
17. J. Hardy, P. Lewis, T. Revesz, A. Lees, and C. Paisan-Ruiz The genetics of Parkinson's syndromes: a critical review Curr. Opin. Genet. Dev. 19 2009 254 265
18. A.H. Schapira Mitochondria in the aetiology and pathogenesis of Parkinson's disease Lancet Neurol. 7 2008 97 109 (Pubitemid 350251942)
19. J.W. Langston, L.S. Forno, J. Tetrud, A.G. Reeves, J.A. Kaplan, and D. Karluk Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure Ann. Neurol. 46 1999 598 605 (Pubitemid 29466438)
20. C.W. Olanow, and S.B. Prusiner Is Parkinson's disease a prion disorder? Proc. Natl. Acad. Sci. USA 106 2009 12571 12572
21. P. Brundin, R. Melki, and R. Kopito Prion-like transmission of protein aggregates in neurodegenerative diseases Nat. Rev. Mol. Cell Biol. 11 2010 301 307
22. H.J. Lee Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies J. Biol. Chem. 285 2010 9262 9272
23. M.P. Smidt, and J.P. Burbach How to make a mesodiencephalic dopaminergic neuron Nat. Rev. Neurosci. 8 2007 21 32 (Pubitemid 46011996)
24. H.H. Simon, H. Saueressig, W. Wurst, M.D. Goulding, and D.D. O'Leary Fate of midbrain dopaminergic neurons controlled by the engrailed genes J. Neurosci. 21 2001 3126 3134 (Pubitemid 32323494)
25. H.H. Simon, S. Thuret, and L. Alberi Midbrain dopaminergic neurons: control of their cell fate by the engrailed transcription factors Cell Tissue Res. 318 2004 53 61 (Pubitemid 39362626)
26. L. Alberi, P. Sgado, and H.H. Simon Engrailed genes are cell-autonomously required to prevent apoptosis in mesencephalic dopaminergic neurons Development 131 2004 3229 3236 (Pubitemid 39077445)
27. P. Sgado Slow progressive degeneration of nigral dopaminergic neurons in postnatal Engrailed mutant mice Proc. Natl. Acad. Sci. USA 103 2006 15242 15247 (Pubitemid 44583195)
28. L. Sonnier, G. Le Pen, A. Hartmann, J.C. Bizot, F. Trovero, M.O. Krebs, and A. Prochiantz Progressive loss of dopaminergic neurons in the ventral midbrain of adult mice heterozygote for Engrailed1 J. Neurosci. 27 2007 1063 1071 (Pubitemid 46203313)
29. M. Di Salvio, L.G. Di Giovannantonio, D. Acampora, R. Prosperi, D. Omodei, N. Prakash, W. Wurst, and A. Simeone Otx2 controls neuron subtype identity in ventral tegmental area and antagonizes vulnerability to MPTP Nat. Neurosci. 13 2010 1481 1488
30. C.Y. Chung, P. Licznerski, K.N. Alavian, A. Simeone, Z. Lin, E. Martin, J. Vance, and O. Isacson The transcription factor orthodenticle homeobox 2 influences axonal projections and vulnerability of midbrain dopaminergic neurons Brain 133 2010 2022 2031
31. R. Torero-Ibad, J. Rheey, S. Mrejen, V. Foster, S. Picaud, A. Prochiantz, and K.L. Moya Otx2 promotes the survival of damaged adult retinal cells and protects against excitotoxic loss of visual acuity in vivo J. Neurosci. 31 2011 5495 5503
32. B. Kadkhodaei Nurr1 is required for maintenance of maturing and adult midbrain dopamine neurons J. Neurosci. 29 2009 15923 15932
33. D. Haubenberger, E. Reinthaler, J.C. Mueller, W. Pirker, R. Katzenschlager, R. Froehlich, T. Bruecke, G. Daniel, E. Auff, and A. Zimprich Association of transcription factor polymorphisms PITX3 and EN1 with Parkinson's disease Neurobiol. Aging. 32 2011 302 307
34. M. Di Salvio, L.G. Di Giovannantonio, D. Omodei, D. Acampora, and A. Simeone Otx2 expression is restricted to dopaminergic neurons of the ventral tegmental area in the adult brain Int. J. Dev. Biol. 54 2010 939 945
35. A. Simeone, M. Di Salvio, L.G. Di Giovannantonio, D. Acampora, D. Omodei, and C. Tomasetti The role of Otx2 in adult mesencephalic-diencephalic dopaminergic neurons Mol. Neurobiol. 43 2010 107 113
36. D. Acampora OTD/OTX2 functional equivalence depends on 5' and 3' UTR-mediated control of Otx2 mRNA for nucleo-cytoplasmic export and epiblast-restricted translation Development 128 2001 4801 4813 (Pubitemid 33138590)
37. J.R. Martinez-Morales, M. Signore, D. Acampora, A. Simeone, and P. Bovolenta Otx genes are required for tissue specification in the developing eye Development 128 2001 2019 2030 (Pubitemid 32600465)
38. A. Nishida, A. Furukawa, C. Koike, Y. Tano, S. Aizawa, I. Matsuo, and T. Furukawa Otx2 homeobox gene controls retinal photoreceptor cell fate and pineal gland development Nat. Neurosci. 6 2003 1255 1263 (Pubitemid 37485118)
39. A. Rebsam, and C.A. Mason Otx2's incredible journey Cell 134 2008 386 387
40. S. Sugiyama, A. Prochiantz, and T.K. Hensch From brain formation to plasticity: insights on Otx2 homeoprotein Dev. Growth Differ. 51 2009 369 377
41. X. Luo, V. Heidinger, S. Picaud, G. Lambrou, H. Dreyfus, J. Sahel, and D. Hicks Selective excitotoxic degeneration of adult pig retinal ganglion cells in vitro Invest. Ophthalmol. Vis. Sci. 42 2001 1096 1106 (Pubitemid 32289809)
42. Lebrun-Julien Excitotoxic death of retinal neurons in vivo occurs via a non-cell-autonomous mechanism J. Neurosci. 29 2009 5536 5545
43. A. Joliot, and A. Prochiantz Transduction peptides: from technology to physiology Nat. Cell Biol. 6 2004 189 196 (Pubitemid 38344356)
44. F. Nagel, B.H. Falkenburger, L. Tonges, S. Kowsky, C. Poppelmeyer, J.B. Schulz, M. Bahr, and G.P. Dietz Tat-Hsp70 protects dopaminergic neurons in midbrain cultures and in the substantia nigra in models of Parkinson's disease J. Neurochem. 105 2008 853 864 (Pubitemid 351562740)
45. G.P. Dietz Membrane-permeable Bcl-xL prevents MPTP-induced dopaminergic neuronal loss in the substantia nigra J. Neurochem. 104 2008 757 765
46. T. Borsello, P.G. Clarke, L. Hirt, A. Vercelli, M. Repici, D.F. Schorderet, J. Bogousslavsky, and C. Bonny A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia Nat. Med. 9 2003 1180 1186 (Pubitemid 37173703)
47. A.C. Bessero, F. Chiodini, E. Rungger-Brandle, C. Bonny, and P.G. Clarke Role of the c-Jun N-terminal kinase pathway in retinal excitotoxicity, and neuroprotection by its inhibition J. Neurochem. 113 2010 1307 1318
48. K. Takahashi, and S. Yamanaka Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors Cell 126 2006 663 676 (Pubitemid 44233629)
49. D. Kim Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins Cell Stem Cell 4 2009 472 476
50. C. Hansen Alpha-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells J. Clin. Invest. 121 2011 715 725
51. A. Recchia, D. Rota, P. Debetto, D. Peroni, D. Guidolin, A. Negro, S.D. Skaper, and P. Giusti Generation of a alpha-synuclein-based rat model of Parkinson's disease Neurobiol. Dis. 30 2008 8 18
52. Z. Yu, X. Xu, Z. Xiang, J. Zhou, Z. Zhang, C. Hu, and C. He Nitrated alpha-synuclein induces the loss of dopaminergic neurons in the substantia nigra of rats PLoS ONE 5 2010 e9956